Clinical Trial Update: Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) [Phase 3]

View source ↗

Summary

The document provides an update on the Phase 3 TAILORx trial evaluating whether adding combination chemotherapy to hormone therapy improves outcomes for women w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Adenocarcinoma, Hormone Receptor Positive | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2019-03-12